1
Corrigendum Corrigendum to ‘‘Mechanisms of action of interferon and nucleoside analogues’’ [J Hepatol 39 (2003) S93–S98] q Howard Thomas * , Graham Foster, Dimitris Platis Department of Medicine A, Imperial College and Liver and Anti-viral Centre, St Mary’s Hospital (QEQM), South Wharf Road, London W2 1NY, UK Declarations of consultancies, funding and relationships that the authors may have with the Pharmaceutical Industry, relating to their work and area of research HC Thomas has stated that he has received funding and/or worked as a consultant for Bristol Myers Squibbs, Gilead, and Roche. Journal of Hepatology 40 (2004) 364 www.elsevier.com/locate/jhep doi:10.1016/j.jhep.2003.12.003 * Corresponding author. Tel.: þ44-207-886-6454; fax: þ44-207-724-9369. q doi of original article 10.1016/S0168-8278(03)00207-1 E-mail address: [email protected] (H. Thomas).

Corrigendum to ‘‘Mechanisms of action of interferon and nucleoside analogues’’ [J Hepatol 39 (2003) S93–S98]

Embed Size (px)

Citation preview

Page 1: Corrigendum to ‘‘Mechanisms of action of interferon and nucleoside analogues’’ [J Hepatol 39 (2003) S93–S98]

Corrigendum

Corrigendum to ‘‘Mechanisms of action of interferonand nucleoside analogues’’

[J Hepatol 39 (2003) S93–S98]q

Howard Thomas*, Graham Foster, Dimitris Platis

Department of Medicine A, Imperial College and Liver and Anti-viral Centre, St Mary’s Hospital (QEQM), South Wharf Road, London W2 1NY, UK

Declarations of consultancies, funding and relationships that the authors may have with the Pharmaceutical Industry,

relating to their work and area of research

HC Thomas has stated that he has received funding and/or worked as a consultant for Bristol Myers Squibbs, Gilead, and

Roche.

Journal of Hepatology 40 (2004) 364

www.elsevier.com/locate/jhep

doi:10.1016/j.jhep.2003.12.003

* Corresponding author. Tel.:þ44-207-886-6454; fax:þ44-207-724-9369.

q doi of original article 10.1016/S0168-8278(03)00207-1

E-mail address: [email protected] (H. Thomas).